View source for 6xqu


==Extreme malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals: Prospects for repurposing existing drugs and ramifications for inhibitor design==
<StructureSection load='6xqu' size='340' side='right'caption='[[6xqu]], [[Resolution|resolution]] 2.20&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6XQU OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6XQU FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=U5G:boceprevir+(bound+form)'>U5G</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6xqu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6xqu OCA], [https://pdbe.org/6xqu PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6xqu RCSB], [https://www.ebi.ac.uk/pdbsum/6xqu PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6xqu ProSAT]</span></td></tr>
</table>

==See Also==
*[[Virus protease 3D structures|Virus protease 3D structures]]
__TOC__
</StructureSection>
[[Category: Large Structures]]
[[Category: Coates L]]
[[Category: Kneller DW]]
[[Category: Kovalevsky A]]